Search

everythinglearnresearchcommunity

for

Search:↓

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

A cat's hair loss was linked to a severe pancreatic cancer.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Bridging anticoagulation may raise post-surgery bleeding risks.

Too much thymosin beta4 causes weird teeth and more hair growth in mice.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.